Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.

Published Date: 14 Jun 2023

LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells lacking in DNA damage repair, according to a recent study that appeared in Oncotarget.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Breast density changes over time are associated with an increased risk of cancer.

2.

How the metastasis of cancer is driven by cellular plasticity.

3.

Belzutifan Combo Could be Second-Line Option in Advanced RCC

4.

Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

5.

Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot